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Abstract: 
In this study, strains isolated from vaginal flora of healthy women were used. 
The anti-proliferative or cytotoxic effects of these strains on the HeLa [Human 
Cervical Carcinoma Cell] and Caco-2 [Human Colon Carcinoma Cell Line] cells 
after various in vitro tests to evaluate the probiotic potential of these strains were 
investigated. All strains were found to be resistant to low pH and high bile salt 
concentrations. It has been determined that vaginal strains have a broad 
spectrum of antimicrobial activity against urogenital pathogens and are resistant 
to frequently prescribed antibiotics for these pathogens. At the end of the 4
th
 
hours, all tested isolates had autoaggregation capacity between 63.6% and 
85.2%. The strains were found to be well coagulated with microorganisms 
(Escherichia coli and Candida albicans) which cause vaginal and urogenital 
infections. In addition, the metabolites of L12, L13 and L19 strains had a 
significant antiproliferative effect (75-90% mortality rate) on the HeLa and Caco-
2 cell lines. These strains with superior probiotic properties alone or with other 
strains having strong probiotic properties can be thought to contribute to the 
development of a new probiotic formulation to help improve maintain urogenital 
health and to reduce the clinical symptoms caused by vaginal infections. 
Keywords: Probiotic, vaginal microbiota, urogenital infections, cervical cancer. 
 
 
  
  
Microbiology                                                       2019;  4(2): 37-43   
 
57 
                                                             PSM Microbiology | https://journals.psmpublishers.org/index.php/microbiol 
INTRODUCTION 
Urogenital infections including bacterial 
vaginosis (BV), aerobic vaginitis, vulvovaginal 
candidiasis (VVC), sexually transmitted diseases 
and urinary tract infections and affect 
approximately one million women worldwide 
every year (Reid et al., 2013). 
Lactobacilli species predominantly found 
in vaginal microbiota play an important role in 
protecting healthy women from genital and 
urogenital infections and preserving the natural 
balance of vaginal microbiota. Long-term studies 
suggest that some women with vaginal 
microbiota without lactobacilli have recurrent 
asymptomatic infections, and that in the majority 
of women, vaginal infections and urinary tract 
infections may cause serious symptoms within 
weeks or months (Stojanovic et al., 2012). 
Lactobacilli are responsible for the 
protection of vaginal microbiota by different 
mechanisms. First of all, lactobacilli bacteria 
produce low vaginal pH with lactic acid and 
prevent the development of potential pathogenic 
microorganisms. Furthermore, lactobacilli 
inhibits the binding of pathogenic 
microorganisms by producing hydrogen 
peroxide, diacetyl, inhibitory enzymes, 
bacteriocin and bacteriocin-like antimicrobial 
agents and adhering to the receptors in the 
vaginal epithelial cells. In addition, they contain 
surface binding proteins that inhibit the binding 
of pathogenic microorganisms to vaginal 
epithelial cells by their coaggregation capabilities 
(Stojanovic, 2012; Stoyancheva et al., 2014; 
George et al., 2018). 
The current definition of probiotics 
recommended by the World Health Organization 
and the Food and Agricultural Organization is 
‘live microorganisms that when administered in 
adequate amounts, confer a health benefit on 
the host’ (FAO/WHO, 2002; Brazilya, 2016). 
Lactic acid bacteria constitute the most 
important group of probiotic microorganisms, but 
lactobacilli species are the most commonly used 
probiotic microorganisms ( Önal et al., 2005). 
The use of probiotic products in the 
prevention and treatment of urogenital infections 
is considered to be an alternative method and it 
has been proven that, as a result of various 
studies, probiotic treatment has reduced or 
prevented the recurrent rate of BV even in high-
risk patients ((Reid et al., 2013; Homayouni et 
al., 2014; Toma´s et al., 2011; Parma et al., 
2014). 
More than a quarter of women with urinary 
tract infections develop recurrent infections 
within six months. The widespread and irregular 
use of antibiotics for treatment increases the 
number of bacteria resistant to antibiotics. 
Therefore, it is considered that probiotic 
capsules or vaginal ovules may be a potential 
alternative, although in recent years there is a 
need for non-antibiotic methods that may be 
effective in protection and treatment (Verdenelli 
et al., 2014; Czaja et al., 2007; Caretto et al., 
2017; Aragon et al., 2016). In this context, there 
is a need to identify strains of superior probiotic 
nature, which have the potential to reduce the 
symptoms of vaginal and urogenital infections, 
treatment and disease. 
Not every microorganism is a probiotic 
and it is necessary to determine the probiotic 
properties of that microorganism by 
experimental and clinical studies in order to use 
a microorganism as a probiotic ( Gulmez and 
Guven, 2002). As the mechanisms of action are 
better understood and the differences between 
the controlled studies and the strains with the 
same genetic structure are well established, the 
predicted probiotic effects of the strains will be 
proven (Schwebke, 2001).  
In the present study was planned in this 
direction; firstly the probiotic properties of 
lactobacilli bacteria isolated from vaginal 
microbiota of healthy women in Kırşehir region 
were investigated by using universal criteria 
such as acid and bile tolerances, antimicrobial 
activities and antagonistic effects on pathogenic 
microorganisms, hydrogen peroxide (H2O2) 
production capabilities, autoaggregation and 
coaggregation capabilities, and binding capacity 
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to uroepithelial cells. Secondly, the anti-
proliferative effect of these probiotic strains on 
HeLa and Caco-2  cells was investigated.  
  
MATERIALS AND METHODS 
Selection of Lactobacilli strains  
In this study, 10 Lactobacillus spp. with 
superior probiotic properties were selected from 
among the strains isolated from vaginal regions 
of 60 healthy women who applied to Kırşehir Ahi 
Evran University Education and Research 
Hospital. Vaginal swabs were taken from 
voluntary patients, aged 18 - 45, without 
menopause, who were not protected by any birth 
control method and did not take antibiotics in the 
last 3 months. In this study, it was ensured that 
healthy patients who had vaginal swab samples 
to be read and signed the informed volunteer 
form.  
All vaginal samples were inoculated onto 
MRS (De Man Rogosa Sharpe, Merck) agar and 
the plates were incubated at 37°C for 48 hours 
under anaerobic conditions. Lactobacilli were 
initially phenotypically identified using colony 
morphology, gram reactions and catalase 
activities, and API (Analytical Profile Index) 50 
CHL test kit (BioMerieux, Inc., France) was used 
for biochemical identification. Gram positive and 
catalase negative colonies were selected and 
stored at -80
o
C in TSB medium containing 20% 
(v / v) glycerol (Schwebke, 2001). 
Inoculation of API50 CHL strips was 
performed according to the manufacturer's 
recommendations. The presence or absence of 
carbohydrate fermentation in the strips was 
checked at 37°C for 48 hours after. The results 
were evaluated using the address 
https://apiweb.biomerieux.com/. 16S rDNA 
sequence analysis was used for the molecular 
identification of strains.  
Identification of lactobacilli by 16S rDNA 
sequencing 
Genomic DNA isolations of the strains 
were performed with Thermo Scientific GeneJET 
Genomic DNA Purification Kit (Kit No: # K0721). 
The repeat 16S rDNA sequence regions in DNA 
samples isolated - 27F forward (5 'AGA GTT 
TGA TCM TGG CTC AG3') and 1429R reverse 
(3 'GGT TAC CTT GTT ACG ACT T5') - were 
performed by using universal primers (Frank et 
al., 2008) and PCR process was conducted with 
Thermo Fisher Scientific Arctic Thermal Cycler 
5020. 
Low pH and high salt tolerance 
 The survival rates of the identified 
lactobacilli at low pH and high bile salt were 
measured by modification from previous studies 
(Maragkoudakis et al., 2006).  The cultures 
which were activated for 18 hours in MRS broth 
were centrifuged at 3000 xg for 15 minutes (4°C) 
and the cells were precipitated. The precipitate 
was washed twice with sterile phosphate 
buffered saline (phosphate-buffered saline 
(PBS) and resuspended again in phosphate 
buffer (pH 7.2) to 8.5 ± 9.1 log CFU/ml. 100 µl 
from the prepared PBS buffer was injected to 
MRS liquid media with pH 2.0, 2.5 and 3.0 and 
containing 0.3%, 0.5% and 1% (w/v) bile salt 
(oxgall, Sigma) and incubated at 37
o
C for 3 
hours. Samples were collected from samples at 
hours 0 and 3 of incubation, and serial dilutions 
were performed up to 10
-7
 level and smears 
were cultivated in MRS solid media in 3 parallel 
forms. After incubation of the strains overnight at 
37
o
C, colonies in the control and test groups 
were counted and their numbers were 
determined as log CFU/mL. 
Survival rate (%) = (log cfu N1/log cfu N0) x 100 
N1: The number of live microorganisms in 
the test group 
N0: The number of live microorganisms in 
the control group 
Antibiotic susceptibility assay of isolates 
Antibiotic susceptibility of isolated strains 
was determined by disk diffusion method 
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(Georgieva et al., 2015) against commonly used 
antibiotics (vancomycin, teicoplanin, penicillin, 
ampicillin, tetracycline, rifampicin, 
chloramphenicol, erythromycin, ciprofloxacin, 
gentamicin, cefazolin, clindamycin, tobramycin, 
amikacin, cefoperazone, aztreonam, 
streptomycin, netilmicin, imipenem, and 
ceftazidime). The density of the activated 
cultures was adjusted to 0.5 McF (625 nm 
absorbance = 0.08-0.1) in tubes containing 
sterile saline and homogenously spread to MRS 
agar plates with the drigalski spatula.  The 
antibiotic discs were placed on the petri dishes 
with a disc dispenser and allowed to incubate at 
37°C for 24 hours. At the end of the incubation 
period, the diameters of the zones around the 
antibiotic discs were measured by calliper in 
millimeters. The antibiotic susceptibility levels of 
the strains were evaluated according to the 2017 
criteria set by EFSA (European Food Safety 
Authorit). Based on the standards, it was 
determined as Resistant (R), Semi-sensitive (I) 
and Sensitive (S)  
Antimicrobial activity assay of isolates 
In this study, the indicator microorganisms 
obtained from Microbiology Culture Collection, 
Faculty of Arts and Sciences and the clinical 
isolates obtained from the Microbiology 
Laboratory,  Medical Faculty of Kırşehir Ahi 
Evran University were used respectively. In 
order to determine the efficiency of the inhibitory 
agents in supernatant fluids of the isolates, well 
diffusion method was used. B. cereus (709) 
Roma, B. cereus CU1065, B. subtilis (American 
Type Culture Collection- ATCC) 6633, C. 
albicans ATCC 90028, C. albicans 10098, C. 
albicans Y-1200-NIH, C. tropicalis ATCC 13803, 
E. coli ATCC 25922, E. faecalis ATCC 29212, K. 
pneumoniae ATCC 13883, P. aeruginosa ATCC 
27853 and S. aureus ATCC 29213, Candida 
glabrata AEÜ1, E. coli AEÜ2, E. coli AEÜ3 
[Broad Spectrum Beta Lactamase positive 
(GSBL+)], E. faecalis AEÜ4, K. pneumoniae 
AEÜ5, P. mirabilis AEÜ6 and S. aureus AEÜ7 
clinical isolates were used as indicator 
organisms. 
The lactobacilli, which was activated 
successively twice in MRS broth (pH 6.5) at 
37°C, was centrifuged at 10.000 x g for 10 min 
(4ºC). The supernatant resulting from the 
centrifugation was sterilized by microfiltration 
under sterile conditions through a 0.45 µm 
(Milipore, USA) disposable filter. 
After pathogen test bacteria were 
activated for 18 hours at 37°C in the appropriate 
media, the final concentration of the cultures 
was distributed homogenously by a sterile 
drigalski spatula to Mueller Hinton Agar (Merck) 
and Potato Dextrose Agar (Merck) media at 1 x 
109 CFU/mL. Wells (6 mm) were formed on the 
plates and 100 µL of sterile supernatants 
obtained from each isolate was transferred to 
these wells. After the plates were kept at room 
temperature for 2 hours, the bacteria were 
allowed to incubate at 37°C and yeast at 30°C 
for 24 hours. Antimicrobial activity was assessed 
by measuring the zone diameter (in mm) around 
the wells and taking the average of three studies 
(Nami et al., 2014a; Maldonado et al., 2012). 
Detection of hydrogen peroxide production 
A semi-quantitative method was used to 
determine the hydrogen peroxide production 
capabilities of lactobacilli (Gil et al., 2010). The 
cultures that were activated overnight in MRS 
liquid broth were allowed to incubate at 37°C for 
48 hours in MRS solid broth. Selected colonies 
(Macherey-Nagel Quantofix Peroxide, Germany) 
were treated with peroxidase-containing strips 
and the image obtained in different shades of 
blue on the test strip was compared with the 
manufacturer's recommended color scale. The 
results were evaluated in consideration of the 
negative test ranges of 1-3, 3-10, 10-30 and 30-
100 mg/L indicated on the test kit.  
Auto-aggregation and co-aggregation assays 
The method practiced by Juárez Tomás et 
al. (2005) was applied for determining auto-
agression characteristics of lactobacilli. The 
cultures activated overnight in MRS broth were 
centrifuged at 6000 x g for 15 minutes. After the 
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precipitate is washed twice with PBS buffer (pH 
6.2), it was resuspended in the UV 
Spectrophotometer (Thermo Scientific Evolution 
60S) with PBS at 600 nm and 0.6 optical density 
(OD). The same process was also prepared for 
use in the coaggregation study for Candida 
albicans ATCC 10231, Escherichia coli ATCC 
25922 and Pseudomonas aeruginosa ATCC 
27853 strains. For each microorganism, cell 
suspensions (4 ml) (auto-aggregation) or each 
lactobacilli (2 ml) and pathogen (2 ml) from 
microorganisms were mixed in equal volumes 
and the resultant mix suspension (co-
aggregation) was vortexed for 10 seconds and 
allowed to rest at room temperature for 4 hours. 
During the incubation, 0.1 ml was taken from the 
upper portion of cultures and diluted with 3.9 ml 
MRS liquid broth and culture ODs before (A0) 
and after (A4) the rest were read in UV 
spectrophotometer at 600 nm (A600). Auto-
aggression percentage was calculated based on 
the formula 1- (A4 /A0) x 100. The coaggregation 
percentage was calculated by the following 
formula:  
 
x & y: 2 genera in the control tubes 
x+y: Mixture 
In order to observe the coaggregation 
study, 500 ul of each lactobacilli isolate was 
mixed with the suspension containing C. 
albicans ATCC 10231, E. coli ATCC 25922 and 
P. aeruginosa ATCC 27853 cell fluids (500 ul) at 
the same concentration, and after a short 
vortexing, the samples were allowed to stir in the 
shaker (50 rpm) for 4 hours. Thereafter, a drop 
of gram suspension taken from this suspension 
was monitored under 100x magnification under 
the light microscope (Leica DM500). Specimens 
were classified by the density of bacteria 
clusters (+1 to +4) (Younes et al., 2012; Santos 
et al., 2016).  
Determining enzyme profiles of vaginal 
lactobacilli 
The cultures developed in MRS medium 
for 18 hours were centrifuged 10.000 g, 10 min, 
4°C) and the precipitant was suspended with 2 
mL of sterile saline (0.89% NaCl) solution and 
the cell density was adjusted to 5-6 McFarlanda. 
65 μL of the suspension prepared in the wells of 
the enzyme impregnated strips in the API ZYM 
kit (Biomerieux, France) was added and the kits 
were allowed to incubate at 37°C for 4-5 hours. 
After incubation, 1 drop of ZYM A and 1 drop of 
ZYM B reagents were added drop wise to the 
wells and allowed to rest for 5 minutes and kept 
under 1000 W light source for 10 sec (Charteris 
et al., 2001). 
 
The color changes and densities of 
the strips were evaluated according to the 
manufacturer's recommendations. 
Adhesion to Uroepithelial Cells 
Uroepithelial cells were obtained from the 
urine of healthy women with high epithelial cell 
density, who applied to Ahi Evran University 
Education and Research Hospital in Kırşehir. 
Uroepithelial cells and cultures activated 
overnight were washed twice with PBS and 
resuspended in PBS to achieve a cell density of 
0.5 McF (625nm = 0.08-0.1). Uroepithelial cells 
without bacterial culture were used as negative 
control. Prepared bacterial cells and uroepithelial 
cells were mixed in equal volumes and allowed 
to incubate at 37°C for 3 hours. After incubation, 
the mixture was washed with PBS and then 
resuspended with PBS to eliminate bacteria that 
were not adhered to the epithelial cells. In order 
to observe the capability of the lactobacilli to 
adhere to epithelial cells, gram staining of the 
mixture suspended with PBS was performed and 
the preparations were observed at 100x 
magnification under the light microscope (Leica 
DM500). The degree of adhesion of bacterial 
cells to epithelial cells is ranked between +1 and 
+4 (Al-Zubaidy et al., 2001).  
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Cancer cell lines and development 
conditions 
HeLa and Caco-2 cell lines were used to 
determine the anticancer activity of the secretory 
metabolites of the vaginal isolates on tumor 
cells. Hela (ATCC CCL2) and Caco-2 (ATCC 
HTB-37) cell lines are commercially available. 
HeLa cells are routinely developed in RPMI 
1640 medium containing 10% fetal bovine 
serum, gentamicin, penicillin, and streptomycin 
antibiotics whereas Caco-2 cells were developed 
in EMEM medium containing L glutamine, 
NaHCO3, Na pyruvate, non-essential amino 
acid, 20% fetal bovine serum in an incubator 
with CO2 (Nüve EC 160). All experiments were 
conducted at 37°C at 5% CO2 atmosphere 
(Merghoub et al., 2009).  
During cell passage of cell cultures, as 
cell lines covered the culture dish their medium 
was taken by a pipette and the culture dish 
surface was washed with PBS. Wash buffer was 
then removed and 1-2 ml of 0.25% trypsin-EDTA 
solution was added depending on the type of cell 
to separate the cells from the culture dish 
surface and from each other for 5 minutes. 4-5 
ml medium was added to inactivate trypsin and 
passages was applied at the desired level and 
cells were transferred to new culture media 
(Parsian et al., 2016). 
Preparing Culture Supernatants 
After the strains with probiotic 
characteristics were developed at 37
o
C for 18 
hours, they were centrifuged 5.000 g, 10 min, 
4
o
C). The pH of the bacterial supernatants was 
adjusted to 7.2 (0.22 µm Milipore, USA). The 
lyophilization process of the sterilized 
supernatants was carried out at -58
o
C in the 
lyophilization device (Labfreez FD-10-R) 
(Haghshenas et al., 2014). 
XTT (Cell proliferation kit) test of vaginal 
lactobacilli 
XTT (Biological Industries, Israel) kit was 
used to evaluate the anti-proliferative action of 
vaginal lactobacilli on HeLa and Caco-2 cells. 
Cells were cultured in 96-well plates overnight 
(24 h) in CO2 incubator and then lyophilized 
culture supernatants were treated with cells for 
72 hours. Relative growth amounts were 
determined by XTT agent (phenazine 
methosulphate) added to wells (Parsian et al., 
2016).  
Statistical Analyses 
A completely randomized experimental 
design was used with three replications in 10 x 2 
and 6 x 4 factorial arrangements. One-way 
analysis of variance was also used. Tukey HSD 
and Dunnet multiple comparison tests were used 
to find out which group originated the difference 
between the groups. The normality assumption 
in the analyses was examined by Kolmogorov-
Smirnov and Shapiro Wilk tests. Statistical 
analyses were performed using SPSS (version 
20.0, SPSS Inc, USA) statistical package 
program. In the analyses, the significance level 
was determined as p <0.05 and p <0.01. 
 
RESULTS 
Idendification of isolates 
In our study, ten lactobacilli strains with 
potential probiotic properties were selected 
among the strains isolated from the vaginal flora 
of healthy Turkish women aged 18-45. The 
selected strains are resistant to high bile salt and 
low pH environment, with good antimicrobial and 
antagonistic activity. Test bacteria selected 
according to morphological and biochemical 
characteristics of gram positive, catalase 
negative, bacilli appearance. Biochemical and 
molecular identification of strains were 
performed by sequence analysis of API-50 CHL 
assay and 16S rDNA gene regions, respectively. 
According to API 50 CHL test, Lactobacillus 
plantarum, Lactobacillus rhamnosus and 
Lactobacillus paracasei strains were compatible 
with 16S rDNA results. According to the results 
of 16S rDNA, 40% of the selected strains are L. 
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plantarum and 30% are L. rhamnosus while 10% 
are L. acidophilus, L. paracasei and one species 
can not be identified. Comparative table, strain 
numbers and NCBI (National Center for 
Biotechnology Information) gene bank numbers 
of selected strains according to 16S rDNA and 
API 50 CHL test kit are given in Table 1. 
 
Table 1. Comparative table of selected isolates according to 16S rDNA and API 50 CHL test kit 
Isolate 
number 
 
API 50 CHL 
16S rDNA 
Genbank 
number 
L12 Lactobacillus rhamnosus Lactobacillus rhamnosus MF155772 
L13 Lactobacillus rhamnosus Lactobacillus rhamnosus MF155773 
L14 Lactobacillus gasseri Lactobacillus acidophilus MF155774 
L15 Lactobacillus rhamnosus Lactobacillus rhamnosus MF155775 
L16 Lactobacillus plantarum 1 Lactobacillus plantarum MF155776 
L17 Lactobacillus plantarum 1 Lactobacillus spp. MF155777 
L18 Lactobacillus plantarum 1 Lactobacillus plantarum MF155778 
L19 Lactobacillus plantarum 1 Lactobacillus plantarum MF155779 
L20 Lactobacillus paracasei Lactobacillus paracasei MF155780 
L21 Lactobacillus paracasei ssp. paracasei 1 Lactobacillus plantarum MF155781 
 
 Low pH and high salt tolerance 
 Lactobacilli were isolated from vaginal 
swabs and their resistance to acid and bile salts 
were determined. All strains could not survive at 
the end of the hours 3 in the pH 2.0 
environment. While the viability of the strains 
was 67.6% at pH 2.5, this rate increased to 
89.3% at pH 3.0. As shown in Table S1 
(Supplementary Table 1), the resistance rates of 
L16, L18 L19 and L21 strains to high bile salt 
media were found to be high, and all other 
strains were found to be resistant to different 
concentrations of bile salts (Table S1). 
Antibiotic susceptibility 
The selected isolates were found to be 
resistant to ciprofloxacin, gentamicin, tobramycin 
and amikacin antibiotics whereas all strains were 
observed to be susceptible toward tetracycline, 
erythromycin, penicillin, ampicillin, imipenem, 
chloramphenicol, antibiotics. It was determined 
that all strains were resistant against 
vancomycin and teicoplanin antibiotics from 
glycopeptide group except L14 and L21 strains. 
The antibiotic resistance profiles of the strains 
are given in Table S2. 
Antimicrobial activity assay 
In the study where the antagonistic activity 
of selected vaginal isolates on pathogens that 
cause urogenital infections and are clinically 
important was investigated. It was observed that 
all strains showed antagonistic activity against 
C. glabrata AEÜ1 ve K. pneumoniae AEÜ5 
strains but none of the strains formed an 
inhibition zone against C. tropicalis ATCC 13803 
and P. mirabilis AEÜ6 strain. It was determined 
that isolates showed antimicrobial activity 
against E. coli ATCC 25922, E. faecalis ATCC 
29212, B. subtilis W168, B. cereus RSKK 709, 
B. cereus CU1065, C. albicans Y-1200-NIH and 
E. coli AEÜ3 (GSBL+). The inhibition zone 
diameters of the strains are shown in Table S3.  
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Detection of hydrogen peroxide production 
 In our study, the rate of H2O2 produced 
by vaginal lactobacilli strains was determined by 
a semiquantitative method. It was determined 
that L19 strains produced the highest level of 
H2O2 at 10 mg/L, while L12, L6, L17 and L21 
strains produced 3 mg/L and other strains did 
not produce any H2O2. 
Auto-aggregation and co-aggregation assays 
As seen in Figure 1, at the end of the 4 h, 
it was determined that the average of all strains 
was 71.8% and the L16 strain had a very high 
autoaggregation capacity with 85.2 %.  L21 
strain was found to have the lowest 
autoaggregation capacity with a rate of 63.6 %. 
Autoaggregation of L15 strain at 1 and 4 h is 
given in Figure 2. In our coaggregation study on 
vaginal strains, it was determined that the 
strains, had good coaggregation with C. albicans 
and E. coli but their coaggregation capabilities 
with P. aeruginosa were found to be low.  As 
shown in Table S4, strains with the best 
coaggregation characteristics were found to be 
L13, L16, L19 and L21. 
 
 
Fig. 1. Graphical representation of auto-aggregation percentage of vaginal lactobacilli 
 
Adhesion to uroepithelial cells vaginal 
lactobacilli 
Throughout this study, uroepithelial cells 
obtained from urine of healthy women were 
used. The adhesion degree of vaginal isolates to 
the uroepithelial cells at the end of the 3
rd
 hours 
is shown in Table S4 and the binding images of 
the L16 and L19 strains are shown in Figure 3. 
As a result of this work, strains with the best 
binding rate to uroepithelial cells were 
determined as L16, L19 and L21. 
Enzyme profiles of vaginal lactobacilli 
According to the reaction results of the 
vaginal lactobacilli with the enzymes in the API 
ZYM test strips, most of the strains were found 
to have high levels of enzyme activity with 
leucine aramidase, valine arylamidase, acid 
phosphatase, naphthol -AS-BI-
phosphohydrolase and α-glucosidase enzymes. 
It was also found out that in moderate reaction 
with esterase (C4), esterase lipase (C8), cystine 
arylamidase, β- galactosidase and β- 
glucosidase enzymes, the strains did not react 
with trypsin, α- mannosidase and β- 
glucuronidase enzymes. 
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Fig. 2. Auto-aggregation of Lactobacilli spp. evaluated 
in a 4- hour study (A) and microphotographies 
(magnification of 100x) showing specifically auto-
agregation of L15 assessed after 1h (A) and 4h (B) of 
incubation at room temperature. 
 
Fig. 3. Grams of L16 and L19 strains showing the 
degree of binding with uroepithelial cells at the end of 
the 3 hour; A (+3); L16, B (+4); L9. 
The antiproliferative action of vaginal 
lactobacilli on HeLa and Caco-2 Cell lines 
The antiproliferative effect of secretion 
metabolites of lactobacilli isolated from vaginal 
microbiota of healthy women on HeLa and 
Caco-2 cell lines were evaluated by XTT method 
(72 h). With LD50 (abbreviation of 50% lethal 
dose) program, in which the average lethal dose 
of a toxic substance is determined in toxicology. 
It was observed that L12 (LD50: 0.009 g/ml), L13 
(LD50: 0.009 g/ml) and L19 (LD50: 0.007 g/ml) 
strains created a significant antiproliferative 
action on HeLa. LD50 values showing the 
antiproliferative effects of vaginal lactobacilli on 
HeLa cells are given in Table S5. 
As shown in Figure S1, approximately 
90% death rate (mortality) was observed in the 
antiproliferative effect of the L19 strain at a dose 
of 0.07 g/ml and the L13 strain at 0.06 g/ml on 
the HeLa cells, however an approximately 75-
80% death rate was observed in the 
antiproliferative effect on the HeLa cells of 0.004 
g/ml dose of L12 metabolite. 
The antiproliferative effect of L12, L13 and L19 
strains on the Caco-2 cell line, which showed 
significant cytotoxic effect on HeLa cell line, 
while approximately 80% death rate was 
observed in the antiproliferative effect of 0.018 
g/ml of L12 metabolite on Caco-2 cells, 
approximately 75% mortality rate was observed 
at a dose of 0.012 g/ml of L13 strain and 0.006 
g/ml of L19 strain. 
 
DISCUSSION 
The effectiveness of probiotics in the 
treatment of urogenital infections and protection 
from recurrent vaginal infections has been 
proven by clinical researches (Borges et al., 
2014; Al-Ghazzewi et al., 2016; Davar et al., 
2016). The studies carried out to determine the 
microorganisms with potential probiotic activity in 
vaginal microbiota have been continuing 
effectively. 
In this study, 10 strains of lactobacilli 
selected from strains isolated from the vaginal 
walls of 60 healthy Turkish women were used. 
The most dominant species among the selected 
strains is L. plantarum.  
In order to have a better effect on the 
health of probiotic microorganisms, it must first 
be resistant to the hard conditions of the 
stomach and small intestine. The low pH of the 
stomach and the antimicrobial effect of pepsins 
are known to act as an effective barrier to the 
entry of bacteria into the gastrointestinal system 
(Kaewnopparat et al., 2013). Many lactobacilli 
strains lose their viability after exposure to low 
pH for 3 hours (Nami et al, 2014a). 
 
In our study, 
it was observed that none of the strains were 
able to maintain their vitality at the end of the 
hour 3 in the pH 2.0. However, the viability of the 
strains was 67.6% at pH 2.5 and this ratio 
increased to 89.3% at pH 3.0. It was found that 
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especially L15, L16, L18 and L20 strains were 
able to maintain high viability in gastric 
conditions and thus maintain sufficient numbers 
for competition and attachment with pathogenic 
bacteria when they reached the digestive tract 
(Nami et al., 2014a; Nami et al., 2014b). Bile 
tolerence is another essential criterion for the 
selection of a probiotic strains. The resistance to 
different salt concentrations in vaginal lactobacilli 
is strain-specific, because the behavior is 
different in strains identified into the same 
species. In the studies, L16, L18 L19 and L21 
strains were found to be highly resistant to high 
bile salt environment as seen in Table 1, and all 
strains were found to be resistant to different 
concentrations of bile salts. 
 Probiotic strains should be sensitive to 
antibiotics. If they do not contain infectious 
antibiotic resistance genes, they are resistant to 
antibiotics (Zhou et al., 2005; Argyri et al., 2013). 
Resistance to vancomycin is the most common 
source of concern. Vancomycin is one of the 
broad-spectrum antibiotics that are effective 
against clinical infections caused by multidrug-
resistant pathogens (Johnson et al., 1990; 
Woodford et al., 1995). In addition, antibiotic 
resistant probiotics are an advantage for patients 
and can be given to patients with antibiotics 
(Kaewnopparat et al., 2013). In our study, all 
strains were found to be resistant to 
ciprofloxacin, gentamicin, tobramycin amikacin, 
netilmicin and cefoperazone antibiotics. In 
addition, except for two strains (L14 and L21), all 
other strains were found to have vancomycin 
and teicoplanin resistance. The strains were 
found to be susceptible to other tested 
antibiotics. The data obtained from this study are 
similar to the previously reported findings (Katla 
et al., 2001; Ammor et al., 2007; Kassaa et al., 
2014). 
 In our study, we investigated the 
antimicrobial activity of vaginal probiotics and 
the antagonistic effect of strains on pathogen 
microorganisms causing urogenital infections 
and vaginal candidiasis was found to be high 
(Van de Wijgert and Verwijs, 2019). Recent 
meta-analysis results show that vaginal 
lactobacilli are promising for the treatment and 
prevention of BV, but have poor efficacy for 
VVC. As shown in Table S3, most of the strains 
except C. tropicalis ATCC 13803 were found to 
be effective on other Candida strains. These 
strains appear promising in the development of 
well-focused probiotics based on new evidence 
targeting female urogenital system diseases. 
Hydrogen peroxide is an active compound 
produced by vaginal lactobacilli, and has been 
proven by several studies that have been shown 
to protect the vaginal microbiota against 
recurrent urinary tract infection and various 
vaginal infections (BV, gonorrhea, HIV) by H2O2-
producing lactobacilli (Knezević et al, 2005). In 
this study, we investigated the H2O2 production 
capabilities of vaginal strains with a 
semiquantitative method, the strain with the 
highest production ability was identified as L. 
plantarum L19. This result differs from the 
results of the other researchers who used 
semiquantitative methods (Wilks et al., 2004).  
The autoaggregation and coaggregation 
capabilities of lactobacilli are one of the most 
important probiotic properties, allowing the 
pathogen microorganisms to serve as a barrier 
against colonization of mucosal surfaces (Guan 
et al., 2017). The strains isolated in our study 
have different autoaggregation capacities. L. 
plantarum L16 (85.2%) constitutes the highest 
percentage of autoaggregation followed by L18 
and L20. 
The presence of the highest 
autoaggregation strain as L. plantarum L16 may 
be that L. plantarum strains contain LysM 
regions capable of binding to cell surfaces and 
polymers containing N-acetylglucosamine 
(Sánchez et al., 2010). The presence of strains 
having different autoaggregation capacity in the 
present study can be explained by the effect of 
such specific compounds. 
In the vaginal coaggregation study, C. 
albicans ATCC 10231, E. coli ATCC 25922 and 
P. aeruginosa ATCC 27853 strains were used to 
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investigate the relationship of lactobacilli with 
pathogenic bacteria. Only some lactobacilli 
gather in clusters and prevent the growth of 
pathogens (Kassaa et al., 2014). The 
coaggregation of lactobacilli species with 
Candida strains is very significant in protecting 
against vaginal yeast infections because 
lactobacilli can create a small environment 
around pathogens via coaggregation and can 
inhibit the spread of pathogens by synthesizing 
high amount of inhibitory agents (Verdenelli et 
al., 2014). It was observed that all strains except 
L14, L17 and L20 had high coaggregation ability 
with C. albicans in the present study. In addition, 
vaginal lactobacilli were found to be well 
coaggregation with E.coli, but they had low 
coaggregation ability with P. aeruginosa. 
FAO (Food and Agriculture Organization) 
reported that one of the most important tests in 
potential probiotic probiotics is the adhesion of 
probiotic microorganism to mucin and human 
epithelial cells (WHO, 2002). The binding of 
lactobacilli to vaginal epithelial cells is defined as 
the first step in the formation of a barrier to 
prevent colonization of opportunistic pathogenic 
microorganisms (Claudia Otero et al., 2007). 
The binding of lactobacilli to epithelial cells is 
due to their biofilm characteristics, as well as 
autoaggregation and surface hydrophobicity 
(Dunne et al., 2001). Several lactobacilli cell 
surface proteins have been characterized as 
putative competitive exclusion factors 
responsible for the suppression of pathogen 
invasion (Nishiyama et al., 2015). In our study, 
uroepithelial cells obtained from urine of healthy 
women were used to determine the binding 
capacity of lactobacilli isolated from vaginal 
microbiota to epithelial cells. The strains 
showing the best binding to uroepithelial cells 
were L16, L19 and L21. 
According to API-ZYM test kit, most of the 
strains have high activity with leucine aramidase, 
valine aramidase, acid phosphatase, naphthol -
AS-BI-phosphohydrolase and α-glucosidase 
enzymes in our study. None of the strains 
showed any reaction with trypsin, α-
mannosidase and β-glucuronidase enzymes. 
When compared with other studies (Herreros et 
al., 2003). it was determined that the enzyme 
activities of the strains were high. 
Probiotics are microorganisms with 
beneficial health effects and different therapeutic 
activities and anti-carcinogenic characteristics. 
Studies have shown that probiotics have high 
apoptic and antiproliferative effects on different 
cancer cell lines such as breast, bladder, colon, 
cervical, liver, and stomach (Ouyang et al., 
2019). In the literature studies, it was observed 
that the studies conducted by the researchers 
mainly focused on the efficacy of probiotics on 
colorectal cancer (Hendler and Zhang, 2018). In 
our study, after the antiproliferative effect of the 
lactobacilli on the cervical cancer cell line, which 
was primarily isolated from vaginal microbiota, 
was determined, strains with antitumor activity 
on HeLa cells were investigated for 
antiproliferative action on the Caco-2 cell line. 
Regarding the antiproliferative action of 
the metabolite products obtained as a result of 
lyophilization of the lactobacilli supernatant 
isolated from vaginal microbiota on the HeLa 
and Caco-2 cancer cell lines, it was observed 
that as the dose of the metabolites tested 
increased, the cytotoxic action on the cells and 
the rate of viability in the cell lines decreased. 
Based on the study, it was observed that all 
strains had a significant antiproliferative action 
on HeLa cell line and especially L12 (LD50: 
0.009 g/ml), L13 (LD50: 0.009 g/ml) and L19 
(LD50: 0.007 g/ml) strains resulted in a 
signification action. The highest antiproliferative 
action on the HeLa and Caco-2 cells was found 
to vary between 75-90% at the highest doses of 
the metabolite products of the L12, L13 and L19 
strains. 
 
CONCLUSION 
In our study which investigated effective 
probiotic strains in maintaining vaginal health 
and protection from vaginal and urogenital 
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infections, it was observed that different probiotic 
characteristics of different strains were 
prominent. In particular, strains L16, L19 and 
L21 show strong probiotic activity and are likely 
to contribute to the development of new probiotic 
products that may be effective in the prevention 
and treatment of vaginal and urogenital 
infections. Each probiotic strain is specific and 
its efficacy should be investigated. Each 
probiotic strain is specific and the strains need to 
be clinically well characterized by in vivo and in 
vitro studies.  
In our study, it was determined that 
various metabolite supernatants belonging to 
L12, L13 and L19 strains were found to have 
antiproliferative effect on cervical and colorectal 
cancer. The data obtained indicate that the 
metabolites of these strains are possible 
candidates that can be used to kill cancerous 
cells or to prevent cancer. It is of great 
importance that the strains alone or in 
combination with other probiotic microorganisms 
can contribute to the development of new 
probiotic formulations as oral, vaginal, dry 
powder or suspension. 
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